Diligence memo · auto-generated · as of July 3, 2026
First China Pharmaceutical Group, Inc.
First China Pharmaceutical Group, Inc. looks over-valued against its niche peers and is dormant on financing cadence.
Businessfiled
First China Pharmaceutical Group, Inc. operates in Pharmaceuticals, based in KUNMING CITY, YUNNAN PROVINCE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
First China Pharmaceutical Group, Inc. has raised $6.8M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.8M on 2011-03-18.
Most recent recorded round closed around 2011-03-18.
Valuation (modeled)modeled
Provath models First China Pharmaceutical Group, Inc. at approximately $146M (range $2.9M–$1.1B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.44× the median modeled value of Seed Pharmaceuticals companies in 2010–2012 (58 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 15.3 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.3× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 47% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 62% of those peers.
Closest niche peers: MediQuest Holdings LLC, Ampla Pharmaceuticals Inc, Biomimetix Pharmaceutical, Inc., Prexa Pharmaceuticals Inc, VIA Pharmaceuticals, Inc..
Peoplefiled
5 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.